Nonimmune hydrops fetalis diagnosed during the second half of pregnancy in southern China

Fetal Diagnosis and Therapy

Volumn 22, Issue 4, 2007, Pages 302-305

  Liao, Can ^a   Wei, Jiaxue ^a   Li, Qiuming ^a   Li, Jian ^a   Li, Lixian ^a   Li, Dongzhi ^a  

^a GUANGZHOU MATERNAL AND NEONATAL HOSPITAL   (China)

Author keywords

Hb Bart's disease; Nonimmune hydrops fetalis; Prenatal diagnosis; Thalassemia

Indexed keywords

ADULT; ALPHA THALASSEMIA; ARTICLE; CHINA; CONTROLLED STUDY; FEMALE; FETUS; FETUS HYDROPS; FETUS MALFORMATION; HOMOZYGOSITY; HUMAN; INFECTION; MAJOR CLINICAL STUDY; NONIMMUNE FETUS HYDROPS; PREGNANCY TERMINATION; PRENATAL DIAGNOSIS; PRENATAL SCREENING; PREVALENCE; PRIORITY JOURNAL; SECOND TRIMESTER PREGNANCY;

ADULT; ALPHA-THALASSEMIA; CHINA; CHROMOSOME ABERRATIONS; CORDOCENTESIS; FEMALE; GESTATIONAL AGE; HEART DEFECTS, CONGENITAL; HEMOGLOBINS, ABNORMAL; HUMANS; HYDROPS FETALIS; PREGNANCY; PREGNANCY COMPLICATIONS, HEMATOLOGIC; PREGNANCY COMPLICATIONS, INFECTIOUS; PRENATAL DIAGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; ULTRASONOGRAPHY, PRENATAL;

EID: 34250323906     PISSN: 10153837     EISSN: None     Source Type: Journal    
DOI: 10.1159/000100796     Document Type: Article

References (17)

1. Warsof SL, Nicolaides KH, Rodeck C: Immune and non-immune hydrops. Clin Obstet Gynecol 1986;29:533-542.
2. Quong Szeα mutation in a Chinese woman. Eur J Haematol 2005;75:259-261.
3. Yang YH, Teng RJ, Tang JR, Yau KI, Huang LH, Hsieh FJ: Etiology and outcome of hydrops fetalis. J Formos Med Assoc 1998;97:16-20.
4. Suwanrath-Kengpol C, Kor-anantakul O, Suntharasaj T, Leetanaporn R: Etiology and outcome of non-immune hydrops fetalis in southern Thailand. Gynecol Obstet Invest 2005;59:134-137.
5. Xu XM, Zhou YQ, Luo GX, Liao C, Zhou M, Chen PY, et al: The prevalence and spectrum of alpha and beta thalassaemia in Guangdong Province: implications for the future health burden and population screening. J Clin Pathol 2004;57:517-522.
6. Liao C, Mo QH, Li J, Li LY, Huang YN, Hua L, et al: Carrier screening for α- and β-thalassemia in pregnancy: the results of an 11-year prospective program in Guangzhou Maternal and Neonatal hospital. Prenat Diagn 2005;25:163-171.
7. McCoy MC, Katz VL, Gould N, Kuller JA: Non-immune hydrops after 20 weeks' gestation: review of 10 years' experience with suggestions for management. Obstet Gynecol 1995;85:578-582.
8. Sohan K, Carroll SG, De La Fuente S, Soothill P, Kyle P: Analysis of outcome in hydrops fetalis in relation to gestational age at diagnosis, cause and treatment. Acta Obstet Gynecol Scand 2001;80:726-730.
9. Lallemand AV, Doco-Fenzy M, Gaillard DA: Investigation of nonimmune hydrops fetalis: Multidisciplinary studies are necessary for diagnosis - review of 94 cases. Pediatr Dev Pathol 1999;2:432-439.
10. Iskaros J, Jauniaux E, Rodeck C: Outcome of nonimmune hydrops fetalis diagnosed during the first half of pregnancy. Obstet Gynecol 1997;90:321-325.
11. Heinonen S, Ryynanen M, Kirkinen P: Etiology and outcome of second trimester non-immunologic fetal hydrops. Acta Obstet Gynecol Scand 2000;79:15-18.
12. Ismail KM, Martin WL, Ghosh S, Whittle MJ, Kilby MD: Etiology and outcome of hydrops fetalis. J Matern Fetal Med 2001;10:175-181.
13. Cubel RC, Garcia AG, Pegado CS, Ramos HI, Fonseca ME, Clewley JP, et al: Human parvovirus B19 infection and hydrops fetalis in Rio de Janeiro, Brazil. Mem Inst Oswaldo Cruz 1996;91:147-151.
14. Yaegashi N: Pathogenesis of nonimmune hydrops fetalis caused by intrauterine B19 infection. Tohoku J Exp Med 2000;90:65-82.
15. Geisler WM: The prozone phenomenon in syphilis testing. South Med J 2004;97:327-328.
16. Swain S, Cameron AD, McNay MB, Howatson AG: Prenatal diagnosis and management of nonimmune hydrops fetalis. Aust NZ Obstet Gynaecol 1999;39:285-290.
17. Anandakumar C, Biswas A, Wong YC, Chia D, Annapoorna V, Arulkumaran S, Ratnam S: Management of non-immune hydrops: 8 years' experience. Ultrasound Obstet Gynecol 1996;8:196-200.